cholib
viatris healthcare limited - fenófíbrat, simvastatin - dýrarannsóknir - lipid breytandi lyf - cholib er fram eins og venjulega meðferð til að fæði og æfing í mikilli hættu hjarta fullorðinn sjúklinga með blönduðum dyslipidaemia til að draga úr kalíum og auka gegn c stigum þegar gegn c stigum eru nægilega stjórnað með sama skammt af sér simvastatin.
leqvio
novartis europharm limited - inclisiran - hypercholesterolemia; dyslipidemias - lipid breytandi lyf - leqvio is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach ldl-c goals with the maximum tolerated dose of a statin, oralone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.
ezetimib/simvastatin krka tafla 10 mg/ 40 mg
krka d.d. novo mesto* - simvastatinum inn; ezetimibe - tafla - 10 mg/ 40 mg
ezetrol tafla 10 mg
n.v. organon* - ezetimibum inn - tafla - 10 mg
ezetimibe alvogen (ezetimibe ratiopharm) tafla 10 mg
alvogen ehf. - ezetimibum inn - tafla - 10 mg
zarator filmuhúðuð tafla 80 mg
upjohn eesv - atorvastatin calcium - filmuhúðuð tafla - 80 mg
zarator filmuhúðuð tafla 40 mg
upjohn eesv - atorvastatin calcium - filmuhúðuð tafla - 40 mg
zarator filmuhúðuð tafla 20 mg
upjohn eesv - atorvastatin calcium - filmuhúðuð tafla - 20 mg
zarator filmuhúðuð tafla 10 mg
upjohn eesv - atorvastatin calcium - filmuhúðuð tafla - 10 mg
ezetimib medical valley tafla 10 mg
medical valley invest ab - ezetimibum inn - tafla - 10 mg